Get FDA 1571 2019-2024

Information and guidance sheet for the completion of the Investigational New Drug Application (IND). (Form FDA 1571). Purpose. An Investigational New Drug Application (IND) is a request for Food and Drug Administration (FDA) authorization to administer an investigational drug to humans.

As commonly used, the term is meant to indicate that each co-investigator is fully responsible for fulfilling all of the obligations of an investigator as identified in 21 CFR 312.60. Thus under 21 CFR 312.3(b), each co- investigator is an investigator, and as such must sign a separate Form FDA 1572.

Tip #1: What is an IND exemption (AKA IND waiver)? An Investigational New Drug Application (IND) exemption request can be submitted to the Food and Drug Administration (FDA) if a drug that is currently lawfully marketed in the US will be used for a research protocol in humans.

In August 2017, FDA updated both the Form FDA 356h (Application to Market a New Drug, Biologic or an Antibiotic Drug for Human Use) and the Form FDA 1571 (Investigational New Drug Application) to include new data fields.

As commonly used, the term is meant to indicate that each co-investigator is fully responsible for fulfilling all of the obligations of an investigator as identified in 21 CFR 312.60. Thus under 21 CFR 312.3(b), each co- investigator is an investigator, and as such must sign a separate Form FDA 1572.

The 1572 has two purposes: 1) to provide the sponsor with information about the investigator's qualifications and the clinical site that will enable the sponsor to establish and document that the investigator is qualified and the site is an appropriate location at which to conduct the clinical investigation, and 2) to ...

Upload the documents into Import Trade Auxiliary Communication System (ITACS). ... Use the find an import office contact page to determine your local import division email address, postal address, and/or FAX number to submit documents outside of ITACS.

A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial.

The Statement of Investigator (Form FDA 1572) is a form that is required to be filled for clinical trials involving investigational drugs or biologics. ... Agreeing to supervise or conduct the investigational trial according to the current study protocol.

A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial.